{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:00:35Z","timestamp":1769198435341,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s12325-013-0024-5","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T10:13:42Z","timestamp":1365675222000},"page":"369-386","source":"Crossref","is-referenced-by-count":4,"title":["Key Advances in Clinical Cardiology"],"prefix":"10.1007","volume":"30","author":[{"given":"Michael","family":"Connolly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian B. A.","family":"Menown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,9]]},"reference":[{"key":"24_CR1","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","volume":"367","author":"MT Roe","year":"2012","unstructured":"Roe MT, Armstrong PW, Fox KAA, et al.; TRILOGY ACS Investigators. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Eng J Med. 2012:367:1297\u20131309.","journal-title":"N Eng J Med."},{"key":"24_CR2","unstructured":"Clinical Trial Results. Prasugrel vs. clopidogrel for acute coronary syndromes patients managed with revascularization \u2014 the TRILOGY ACS trial. Available at: http:\/\/clinicaltrialresults.org\/Slides\/ESC%202012\/TRILOGY%20ACS%20LBCT%20Presentation%20Draft%208.25.12%20Final%20 Version.ppt. Accessed Feb 18 2013."},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","volume":"366","author":"JL Mega","year":"2012","unstructured":"Mega JL, Braunwald E, Wiviott SD, et al.; ATLAS ACS2-TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012:366:9\u201319.","journal-title":"N Engl J Med."},{"key":"24_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","volume":"366","author":"P Tricoci","year":"2012","unstructured":"Tricoci P, Huang Z, Held C, et al.; TRA2P-TIMI 50 Steering Committee Investigators. Vorapaxar for secondary prevention of thrombotic events for patients with prior myocardial infarction. N Engl J Med. 2012;366:20\u201333.","journal-title":"N Engl J Med"},{"key":"24_CR5","volume-title":"European Society of Cardiology","author":"R Marcucci","year":"2012","unstructured":"Marcucci R, Gori M, Valenti R, et al. Global high on-treatment platelet reactivity identifies patients at high risk of ischemic events: data from RECLOSE 2-ACS study. Oral Presentation. European Society of Cardiology; Aug 2012; Munich."},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/2012.jama.11193","volume":"308","author":"PA Gurbel","year":"2012","unstructured":"Gurbel PA, Erlinge D, Ohman EM, et al.; TRILOGY ACS Platelet Function Substudy Investigators. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization. The TRILOGY ACS platelet function substudy. JAMA. 2012;308:1785\u20131794.","journal-title":"JAMA"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","volume":"367","author":"JP Collet","year":"2012","unstructured":"Collet JP, Cuisset T, Range G, et al.; ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med. 2012;367:2100\u20132109.","journal-title":"N Engl J Med"},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2012.426","volume":"307","author":"HP Selker","year":"2012","unstructured":"Selker HP, Beshansky JR, Sheehan PR, et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes. JAMA. 2012;307:1925\u20131933.","journal-title":"JAMA"},{"key":"24_CR9","unstructured":"Clinical Trial Results. Results of the IMMEDIATE (Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care) Trial: a double-blinded randomized controlled trial of intravenous glucose, insulin & potassium (GIK) for acute coronary syndromes in emergency medical services. Available at: http:\/\/clinicaltrialresults.org\/Slides\/ACC2012\/Selker_IMMEDIATEtrial.pdf . Accessed Feb 18 2013."},{"key":"24_CR10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/2012.jama.11348","volume":"308","author":"E Puymirat","year":"2012","unstructured":"Puymirat E, Simon T, Steg PG, et al.; USIK USIC 2000 Investigators; FAST MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308:998\u20131006.","journal-title":"JAMA"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","volume":"367","author":"ME Farkouh","year":"2012","unstructured":"Farkouh ME, Domanski M, Sleep LA, et al.; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375\u20132384.","journal-title":"N Engl J Med"},{"key":"24_CR12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B Bruyne de","year":"2012","unstructured":"de Bruyne B, Pijls N, Kalesan B, et al.; FAME 2 Trial Investigators. Fractional flow reserve guided PCI versus medical treatment in stable coronary disease. N Engl J Med. 2012;367:991\u20131001.","journal-title":"N Engl J Med"},{"key":"24_CR13","unstructured":"Fearon WK. A prospective, randomized trial evaluating the cost-effectiveness of FFR-guided PCI in patients with stable coronary artery disease. Oral presentation. Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium; October 22\u201326, 2012; Miami, FL."},{"key":"24_CR14","unstructured":"Serruys P. LEADERS: 5-year follow-up. Oral presentation. Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium; October 22\u201326, 2012; Miami, FL."},{"key":"24_CR15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.2012.10065","volume":"308","author":"L R\u00fcber","year":"2012","unstructured":"R\u00fcber L, Kelb\u00e6k H, Ostojic M, et al.; COMFORTABLE AMI Trial Investigators. Effect of Biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA. 2012;308:777\u2013787.","journal-title":"JAMA"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)61852-2","volume":"381","author":"PC Smits","year":"2013","unstructured":"Smits PC, Hofma S, Togni M, et al. Abluminal biodegradable polymer Biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, noninferiority trial. Lancet. 2013;381:651\u2013660.","journal-title":"Lancet"},{"key":"24_CR17","volume-title":"VALENTINES II registry. Oral Presentation","author":"A Serra","year":"2012","unstructured":"Serra A. VALENTINES II registry. Oral Presentation. Cardiovascular Research Technologies; February 4\u20137, 2012; Washington, DC."},{"key":"24_CR18","unstructured":"Bernat I. STEMI-RADIAL: A prospective, randomized trial of radial vs. femoral access in patients with ST-segment elevation myocardial infarction. Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium; October 22\u201326, 2012; Miami, FL."},{"key":"24_CR19","volume-title":"EuroIntervention","author":"M Hamon","year":"2013","unstructured":"Hamon M, Pristipino C, Di Mario C, et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care and Thrombosis of the European Society of Cardiology. EuroIntervention. 2013;pii:20130115-02."},{"key":"24_CR20","unstructured":"Dewilde W, Oirbans T, Verheugt F, et al. What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing. Presented at: European Society of Cardiology 2012 Congress; August 29, 2012; Munich, Germany."},{"key":"24_CR21","unstructured":"Clinical Trial Results. The WOEST Trial: First randomised trial comparing two regimens with and without aspirin in patients on oral anticoagulant therapy undergoing coronary stenting. Available at: http:\/\/www.clinicaltrialresults.org\/Slides\/ESC%202012\/Ten%20Berg_ESC%20WOEST%20 2012.ppt . Accessed Feb 18 2013."},{"key":"24_CR22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann FJ, et al.; IABPSHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock (SHOCK II). N Engl J Med. 2012;367:1287\u20131296","journal-title":"N Engl J Med"},{"key":"24_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.112.132209","volume":"127","author":"D Perera","year":"2013","unstructured":"Perera D, Stables R, Clayton T, et al.; BCIS-1 Investigators. Long-term mortality data from the Balloon Pump-Assisted Coronary Intervention Study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013;127:207\u2013212.","journal-title":"Circulation"},{"key":"24_CR24","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"C Smith","year":"2011","unstructured":"Smith C, Leon L, Mack MJ, et al.; PARTNER Trial Investigators. Transcatheter versus surgical aorticvalve replacement in high-risk patients. N Engl J Med. 2011;364:2187\u20132198.","journal-title":"N Engl J Med"},{"key":"24_CR25","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa1200384","volume":"366","author":"K Susheel","year":"2012","unstructured":"Susheel K, Kodali, Mathew R, et al.; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686\u20131695.","journal-title":"N Engl J Med"},{"key":"24_CR26","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.jacc.2010.01.029","volume":"55","author":"T Keller","year":"2010","unstructured":"Keller T, Tizkas S, T Zeller, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol. 2010;55:2096\u20132106.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR27","unstructured":"Berliner D, Deubner N, Fenske W, et al. Copeptin in heart failure: associations with clinical characteristics and prognosis. European Society of Cardiology 2012 Congress; August 29, 2012; Munich, Germany. Abstract 527."},{"key":"24_CR28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","volume":"380","author":"SD Solomon","year":"2012","unstructured":"Solomon SD, Zile M, Pieske B, et al.; Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet 2012;380:1387\u20131395.","journal-title":"Lancet"},{"key":"24_CR29","unstructured":"Edelmann F, Wachter R, Schmidt A, et al. Aldosterone receptor blockade in diastolic heart failure. Presented at: European Society of Cardiology 2012 Congress; August 29, 2012; Munich, Germany."},{"key":"24_CR30","unstructured":"Budera P, Straka Z, Osmancik P, et al. PRAGUE-12 trial: randomized open multicenter study comparing cardiac surgery with MAZE versus cardiac surgery without MAZE in patients with coronary and\/or valvular heart disease and with atrial fibrillation. Presented at: European Society of Cardiology 2012 Congress; August 29, 2012; Munich, Germany."},{"key":"24_CR31","unstructured":"Curtis AB. Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block (BLOCK HF) trial. Oral presentation. American Heart Association; November 3\u20137, 2012; Los Angeles, CA."},{"key":"24_CR32","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","volume":"367","author":"AJ Moss","year":"2012","unstructured":"Moss AJ, Schuger C, Beck CA, et al.; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275\u20132283.","journal-title":"N Engl J Med"},{"key":"24_CR33","unstructured":"Lonn E. Glucose reduction and atherosclerosis continuing evaluation. Oral presentation: European Society of Cardiology 2012 Congress; August 29, 2012; Munich, Germany."},{"key":"24_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2009.04.019","volume":"158","author":"K Teo","year":"2009","unstructured":"Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S; PURE Investigator-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158:1\u20137.","journal-title":"Am Heart J"},{"key":"24_CR35","unstructured":"Krum H, Schlaich M, Schmieder R, et al. Renal sympathetic denervation for the treatment of resistant hypertension: 18 month results from the SYMPLICITY HTN randomized control trial. Presented at: European Society of Cardiology 2012 Congress; August 29, 2012; Munich, Germany."},{"key":"24_CR36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","volume":"366","author":"PR Schauer","year":"2012","unstructured":"Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567\u20131576.","journal-title":"N Engl J Med"},{"key":"24_CR37","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","volume":"367","author":"GG Schwartz","year":"2012","unstructured":"Schwartz GG, Olsson AG, Abt M, et al.; dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012;367:2089\u20132099.","journal-title":"N Engl J Med"},{"key":"24_CR38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","volume":"381","author":"M Cuchel","year":"2013","unstructured":"Cuchel M, Meagher E, du toit Theron HDT, et al. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet. 2013;381:40\u201346.","journal-title":"Lancet"},{"key":"24_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)60771-5","volume":"380","author":"EA Stein","year":"2012","unstructured":"Stein EA, Gipe D, Bergeron J, et al. Effect of a monoclonal antibody to PCSK9, REGN727\/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial. Lancet. 2012;380:29\u201336.","journal-title":"Lancet"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0024-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-013-0024-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0024-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:56:03Z","timestamp":1559462163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-013-0024-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s12325-013-0024-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}